A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pirbuterol
Periciazine
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Periciazine.
Pirbuterol
Lumacaftor
The serum concentration of Mirabegron can be decreased when it is combined with Lumacaftor.
Pirbuterol
Desvenlafaxine
Desvenlafaxine may increase the tachycardic activities of Mirabegron.
Pirbuterol
Milnacipran
Milnacipran may increase the tachycardic activities of Mirabegron.
Pirbuterol
Metergoline
Metergoline may increase the hypertensive and vasoconstricting activities of Mirabegron.
Pirbuterol
Terguride
Terguride may increase the hypertensive and vasoconstricting activities of Mirabegron.
Pirbuterol
Dihydroergocryptine
Dihydroergocryptine may increase the hypertensive and vasoconstricting activities of Mirabegron.
Pirbuterol
Dihydroergocristine
Dihydroergocristine may increase the hypertensive and vasoconstricting activities of Mirabegron.
Pirbuterol
Dihydroergocornine
Dihydroergocornine may increase the hypertensive and vasoconstricting activities of Mirabegron.
Pirbuterol
Solifenacin
The risk or severity of adverse effects can be increased when Mirabegron is combined with Solifenacin.
Pirbuterol
Trabectedin
The serum concentration of Mirabegron can be increased when it is combined with Trabectedin.
Pirbuterol
Enasidenib
The serum concentration of Mirabegron can be increased when it is combined with Enasidenib.
Pirbuterol
Ponatinib
The serum concentration of Ponatinib can be increased when it is combined with Mirabegron.
Pirbuterol
Dacomitinib
The serum concentration of Mirabegron can be increased when it is combined with Dacomitinib.
Pirbuterol
Neostigmine
Neostigmine may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Capsaicin
Capsaicin may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Methylphosphinic Acid
Methylphosphinic Acid may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Posiphen
Posiphen may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Tretamine
Tretamine may increase the neuromuscular blocking activities of Mirabegron.
Pirbuterol
Distigmine
Distigmine may increase the neuromuscular blocking activities of Mirabegron.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3